1205 KIMBALL BLVD., JASPER, IN
Reports Q3 Results With Double-Digit Sequential Medical Sales Growth; Affirms Guidance For Fiscal 2026 With Adjusted Operating Margin Expected At High End Of Range
Releases 2025 Annual Sustainability Report
Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Raises Its Guidance for Fiscal 2026
Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis
Shareholders Reelect Class II Directors at Annual Meeting
Reports Q1 Results; Reiterates Guidance for Fiscal 2026
Annual Report to Security Holders
Reports Q4 Results With Solid Finish To The Fiscal Year; Provides Guidance For Fiscal 2026
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Annual Report of Employee Stock Purchase Transition